Related Experiment Video

Updated: Apr 14, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)

Zhiyuan Han1, Yanbin Zhang2, Qiaoyuan Yang1

  • 1State Key Laboratory of Respiratory Disease, Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou, P.R. China.

Oncotarget
|April 25, 2015
PubMed

Insights

MicroRNAs miR-497 and miR-34a target CCNE1, inhibiting lung cancer cell growth. Their combined action shows synergistic effects, offering potential therapeutic strategies for cancer.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Cyclin E1 (CCNE1) is crucial for cell cycle progression and is implicated in oncogenesis.
  • CCNE1 overexpression is linked to chromosome instability and tumor development.
  • MicroRNAs (miRNAs) are key regulators of gene expression and can act as tumor suppressors.

Purpose of the Study:

  • To investigate the regulatory relationship between miR-497, miR-34a, and CCNE1.
  • To evaluate the therapeutic potential of miR-497 and miR-34a in inhibiting human lung cancer growth.

Main Methods:

  • Target validation using 3'-UTR assays.
  • In vitro cell proliferation and colony formation assays.
  • In vivo xenograft tumor growth studies.
  • Ectopic expression of miRNAs and CCNE1.

Main Results:

  • miR-497 and miR-34a were found to directly target the 3'-UTR of CCNE1.
  • Both miRNAs were downregulated in cancer cells.
  • Ectopic expression of miR-497 and miR-34a inhibited proliferation, colony formation, and tumor growth.
  • Simultaneous overexpression of both miRNAs exhibited stronger inhibitory effects than individual expression, indicating synergy.
  • Synergistic effects were partly attributed to CCNE1 downregulation.

Conclusions:

  • miR-497 and miR-34a function as tumor suppressors by downregulating CCNE1.
  • The combined action of miR-497 and miR-34a demonstrates synergistic inhibition of human lung cancer cell growth.
  • These findings highlight the potential of miR-497 and miR-34a as therapeutic agents for lung cancer.
Keywords:
CCNE1lung cancermiR-34amiR-497

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K